Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 May;40(2):523–528. doi: 10.1128/iai.40.2.523-528.1983

Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.

A Robinson, L I Irons
PMCID: PMC264886  PMID: 6301999

Abstract

The effect of low levels of added lymphocytosis-promoting factor (LPF) on the ability of several antigenic preparations isolated from Bordetella pertussis and other bacteria to protect mice against intracerebral infection with B. pertussis was examined. LPF was found to enhance the protective activities of filamentous hemagglutinin, 22S antigen, and fimbriae isolated from B. pertussis. Outer membrane protein preparations from phase I B. pertussis which had LPF removed by haptoglobin affinity columns or inactivated by glutaraldehyde, sodium dodecyl sulfate, or Formalin had reduced protective activities but were made fully protective by the readdition of LPF. Similarly, outer membrane protein preparations from Bordetella bronchiseptica, Bordetella parapertussis, or phase IV B. pertussis lacking LPF were protective only when low levels of LPF were added to the preparations. Outer membrane protein preparations from Neisseria gonorrhoeae or Escherichia coli were nonprotective even in the presence of added LPF. The purified LPF by itself was nonprotective unless treated with glutaraldehyde. LPF that had been detoxified with glutaraldehyde was, however, ineffective at enhancing the protective activity of antigenic preparations. The synergistic effect of LPF is discussed in relation to its known biological properties.

Full text

PDF
523

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amiel S. A. The effects of Bordetella pertussis vaccine on cerebral vascular permeability. Br J Exp Pathol. 1976 Dec;57(6):653–662. [PMC free article] [PubMed] [Google Scholar]
  2. Ashworth L. A., Fitzgeorge R. B., Irons L. I., Morgan C. P., Robinson A. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J Hyg (Lond) 1982 Jun;88(3):475–486. doi: 10.1017/s0022172400070339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashworth L. A., Irons L. I., Dowsett A. B. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun. 1982 Sep;37(3):1278–1281. doi: 10.1128/iai.37.3.1278-1281.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dolby J. M., Dolby D. E., Bronne-Shanbury C. J. The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice. J Hyg (Lond) 1975 Feb;74(1):85–102. doi: 10.1017/s002217240004674x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Iida T., Tajima M. Stimulation of non-specific resistance by heterologous endotoxins and experimental immunity to Bordetella pertussis in mice. Immunology. 1971 Aug;21(2):313–322. [PMC free article] [PubMed] [Google Scholar]
  6. Irons L. I., MacLennan A. P. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography. Biochim Biophys Acta. 1979 Sep 29;580(1):175–185. doi: 10.1016/0005-2795(79)90208-3. [DOI] [PubMed] [Google Scholar]
  7. Kendrick P. L., Eldering G., Dixon M. K., Misner J. Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge. Am J Public Health Nations Health. 1947 Jul;37(7):803–810. [PMC free article] [PubMed] [Google Scholar]
  8. MACLENNAN A. P. Specific lipopolysaccharides of Bordetella. Biochem J. 1960 Feb;74:398–409. doi: 10.1042/bj0740398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Morse S. I., Morse J. H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med. 1976 Jun 1;143(6):1483–1502. doi: 10.1084/jem.143.6.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Munoz J. J., Arai H., Bergman R. K., Sadowski P. L. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun. 1981 Sep;33(3):820–826. doi: 10.1128/iai.33.3.820-826.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Munoz J. J., Arai H., Cole R. L. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun. 1981 Apr;32(1):243–250. doi: 10.1128/iai.32.1.243-250.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Preston N. W., Stanbridge T. N. Mouse or man? Which are pertussis vaccines to protect? J Hyg (Lond) 1976 Apr;76(2):249–256. doi: 10.1017/s0022172400055145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Robinson A., Hawkins D. C. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis. Infect Immun. 1983 Feb;39(2):590–598. doi: 10.1128/iai.39.2.590-598.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sato Y., Arai H., Suzuki K. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun. 1974 May;9(5):801–810. doi: 10.1128/iai.9.5.801-810.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Swanson J. Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci. Infect Immun. 1978 Jan;19(1):320–331. doi: 10.1128/iai.19.1.320-331.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES